CytoRecovery
PrivateLast Round
Accelerator
Jun 3, 2024
Total Funding Raised
$4.05M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CytoRecovery operates in Healthcare & Life Sciences and is based in Blacksburg, Virginia. Its latest recorded funding round was an Accelerator round in June 2024.
CytoRecovery is a biotechnology company that develops microfluidic technology designed to recover biological cells from samples.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytoRecovery Comparables
Compare CytoRecovery with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| On-chip Biotechnologies Co., Ltd. | 85% | |
| LevitasBio | 83% | |
| NanoCellect Biomedical | 81% |
For institutional investors. Book with your work email.
CytoRecovery Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 3, 2024 | ||||
| Grant | Feb 9, 2023 | ||||
| Seed | Dec 1, 2022 | ||||
| Seed | Jul 18, 2022 | ||||
| Convertible Debt | Apr 22, 2019 | ||||
Pre Seed | Oct 19, 2018 |
For institutional investors. Book with your work email.
CytoRecovery Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Virginia LVG Seed Fund | Seed |
| Common Wealth Angels | Convertible Debt, Seed |
| Virginia Innovation Partnership Corporation | Convertible Debt |
| The Launch Place | Seed, Pre Seed |
| BioTools Innovator | Accelerator |
| Bloomfield Partners | Convertible Debt, Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 31% MoM, from 1.5K to 2K.
- Jul 20, 2026
Open roles increased from 0 to 4, representing 80% of headcount.
For institutional investors. Book with your work email.
CytoRecovery Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CytoRecovery's valuation, stock price, and market status.
Is CytoRecovery a public or private company?
CytoRecovery is a private company.
What is the current stock price of CytoRecovery?
CytoRecovery is a private company, so its shares have no public market price. Caplight tracks CytoRecovery's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CytoRecovery worth (valuation)?
Valuation information for CytoRecovery is not publicly available.
Can I buy CytoRecovery stock?
CytoRecovery shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CytoRecovery's last funding round?
CytoRecovery's most recent funding round was Accelerator on June 3, 2024.
Who are the main investors in CytoRecovery?
Key investors in CytoRecovery include The Launch Place.
Will CytoRecovery IPO soon?
No public IPO plans have been announced for CytoRecovery.
How can I track CytoRecovery secondary market activity?
Caplight tracks bids, offers, and trades in CytoRecovery's shares on secondary markets.